---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-093566"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2026-08-25T21:00:56+00:00"
generated_at: "2026-08-25T21:02:43.446535+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BioRestorative Therapies receives Nasdaq delisting notice for late 10-Q filing

## Summary
- Received Nasdaq delinquency notice on Aug 21, 2026 for failure to file Form 10-Q for Q2 2026.
- Must submit compliance plan by Oct 20, 2026; Nasdaq may grant extension until Feb 16, 2027.
- Listing continues on Nasdaq Capital Market under BRTX; no immediate delisting effect.
- Company plans to file 10-Q and submit plan; may appeal if plan rejected.

## SEC filing metadata
- accession: 0001213900-26-093566
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2026-08-25T21:00:56+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000121390026093566/0001213900-26-093566-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000121390026093566/ea0303388-8k_biorestorative.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-093566
- JSON: https://secwatch.observer/filing/0001213900-26-093566.json
- Plain text: https://secwatch.observer/filing/0001213900-26-093566.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.